Atrium mapping algorithms for atrial ablation receive FDA clearance, CE mark
Click Here to Manage Email Alerts
Acutus Medical announced that its suite of new algorithms for the mapping and ablation of complex atrial arrhythmias received FDA clearance and CE mark approval.
According to a company press release, the new suite (AcQMap 8) consists of two mapping algorithms (AcQTrack and SlowZone Locator) that are incorporated into the company’s foundational imaging and mapping system (AcQMap 3D).
The first of the new algorithms (AcQTrack) is designed to automatically identify and analyze the presence of three abnormal conduction patterns associated with atrial fibrillation, according to the release. The second algorithm (SlowZone Locator) is engineered to allow physicians to create one or more maps in the atria, which are then combined into a composite map for analyzing areas of consistent slow conduction in each patient.
“Our goal is to give physicians the tools they need to efficiently and effectively treat complex arrhythmias like atrial fibrillation,” Vince Burgess, president and CEO of Acutus Medical, said in the release. “We continue to push the boundaries of what’s possible in the [electrophysiology] lab and take significant technological strides designed to improve patients’ outcomes. AcQMap 8’s unique automated mapping algorithms and functionalities are a much-needed next step as we continue to drive innovation in the electrophysiology space and help physicians create optimized and personalized treatment strategies for all of their patients.”
Collapse
Click Here to Manage Email Alerts